Silver Oak Securities Incorporated Takes $196,000 Position in DocuSign, Inc. (NASDAQ:DOCU)

Silver Oak Securities Incorporated acquired a new stake in shares of DocuSign, Inc. (NASDAQ:DOCU) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 2,133 shares of the company’s stock, valued at approximately $196,000.

Other institutional investors have also modified their holdings of the company. Itau Unibanco Holding S.A. purchased a new position in DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group purchased a new position in shares of DocuSign in the third quarter valued at approximately $33,000. Modus Advisors LLC acquired a new stake in shares of DocuSign in the fourth quarter worth approximately $36,000. Reston Wealth Management LLC purchased a new stake in shares of DocuSign during the third quarter worth approximately $47,000. Finally, Avior Wealth Management LLC lifted its holdings in DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after purchasing an additional 145 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Price Performance

NASDAQ DOCU opened at $90.48 on Monday. The stock has a market capitalization of $18.28 billion, a P/E ratio of 18.66, a PEG ratio of 7.56 and a beta of 0.89. The firm’s 50-day moving average is $92.58 and its two-hundred day moving average is $74.33. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Morgan Stanley raised their target price on shares of DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Friday, December 6th. Robert W. Baird upped their price target on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. UBS Group boosted their price objective on DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research note on Friday, December 6th. Finally, Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $92.45.

Insider Transactions at DocuSign

In other DocuSign news, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the sale, the chief executive officer now owns 100,062 shares of the company’s stock, valued at $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Daniel D. Springer sold 581,588 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total value of $56,437,299.52. Following the transaction, the director now owns 906,430 shares of the company’s stock, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 685,773 shares of company stock worth $66,032,726. 1.66% of the stock is currently owned by insiders.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.